Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A J Scheen

Showing results (141-150 of 787) with videos related to

Pageof 79
Sort By:
Revue Medicale De Liege|August 28, 2014
[Alogliptin (Vipidia): a selective DPP-4 inhibitor with a good cardiovascular safety]A J Scheen
Revue Medicale De Liege|July 30, 2013
[Workaholism, another form of addiction]A J Scheen
Revue Medicale De Liege|August 11, 2017
[Editorial- From the notion of "good health" to exemplary pathological cases]A J Scheen
Revue Medicale De Liege|October 21, 2004
[How I explore...the absolute cardiovascular risk at 10 years: from Framingham 1998 to SCORE 2003]A J Scheen
Diabetes & Metabolism|January 27, 2005
Renin-angiotensin system inhibition prevents type 2 diabetes mellitus. Part 2. Overview of physiological and biochemical mechanismsA J Scheen
Revue Medicale De Liege|November 25, 2003
[Medication of the month. Vardenafil (Levitra)]A J Scheen
Minerva Endocrinologica|July 17, 2004
Management of the metabolic syndromeA J Scheen
Acta Clinica Belgica|April 8, 2004
Pathophysiology of type 2 diabetesA J Scheen
Revue Medicale De Liege|June 1, 1992
[Quantitative study of the secretion, action and metabolism of insulin in man]A J Scheen
Lancet (London, England)|September 12, 2006
Does the metabolic syndrome help to select patients requiring high statin dose?A J Scheen
Pageof 79

Showing results (141-150 of 787) with videos related to

Sort By:
Pageof 79
Revue Medicale De Liege|August 28, 2014
[Alogliptin (Vipidia): a selective DPP-4 inhibitor with a good cardiovascular safety]A J Scheen
Revue Medicale De Liege|July 30, 2013
[Workaholism, another form of addiction]A J Scheen
Revue Medicale De Liege|August 11, 2017
[Editorial- From the notion of "good health" to exemplary pathological cases]A J Scheen
Revue Medicale De Liege|October 21, 2004
[How I explore...the absolute cardiovascular risk at 10 years: from Framingham 1998 to SCORE 2003]A J Scheen
Diabetes & Metabolism|January 27, 2005
Renin-angiotensin system inhibition prevents type 2 diabetes mellitus. Part 2. Overview of physiological and biochemical mechanismsA J Scheen
Revue Medicale De Liege|November 25, 2003
[Medication of the month. Vardenafil (Levitra)]A J Scheen
Minerva Endocrinologica|July 17, 2004
Management of the metabolic syndromeA J Scheen
Acta Clinica Belgica|April 8, 2004
Pathophysiology of type 2 diabetesA J Scheen
Revue Medicale De Liege|June 1, 1992
[Quantitative study of the secretion, action and metabolism of insulin in man]A J Scheen
Lancet (London, England)|September 12, 2006
Does the metabolic syndrome help to select patients requiring high statin dose?A J Scheen
Pageof 79